title: No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis.
authors.forename: P
authors.initials: P
authors.lastname: Härle
authors.forename: P
authors.initials: P
authors.lastname: Sarzi-Puttini
authors.forename: M
authors.initials: M
authors.lastname: Cutolo
authors.forename: R H
authors.initials: RH
authors.lastname: Straub
mesh_terms: D000068879:Adalimumab; D052242:Adiponectin / Q000097:blood*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000188:drug therapy / Q000276:immunology; D005260:Female; D006801:Humans; D020738:Leptin / Q000097:blood*; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D052242:Adiponectin; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D020738:Leptin; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab